C07D 311 - Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings

Patents for C07D 311 - Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings (24,127)
12/1999
12/01/1999	EP0800504B1 Tricyclic retinoids, methods for their production and use
12/01/1999	EP0783537B1 Cumarin and quinolinone derivatives for preparing liquid crystal orientation layers
12/01/1999	CN1237163A Process for manufacturing d, 1-alpha-tocopherol
11/1999
11/30/1999	US5994544 Producing a 5h-chromeno(3,4-f)quinoline
11/30/1999	US5994508 Isoflavone rich protein isolate and process for producing
11/30/1999	US5994413 Pressing, extraction
11/30/1999	US5994390 Trans-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes
11/25/1999	WO1999059989A1 Process for the preparation of a benzo fused heterocyclo sulfonyl halide intermediate
11/25/1999	WO1999059988A1 New process
11/25/1999	WO1999059966A1 METHOD OF LOCKING 1α-OH OF VITAMIN D COMPOUNDS IN AXIAL ORIENTATION
11/25/1999	DE19922287A1 Cosmetic, dermatological, pharmaceutical, dietetic or food compositions, e.g. for improving skin condition, comprise flavonoid esters
11/25/1999	CA2333103A1 Method of locking 1.alpha.-oh of vitamin d compounds in axial orientation
11/24/1999	EP0958291A1 3-heterocyclyl-substituted benzoyl derivatives
11/24/1999	EP0958288A1 Photochromic naphtopyrane colorants, method for the production and use thereof, photochromic object
11/24/1999	EP0957911A1 HESPERIDIN AND HESPERETIN AS 3-HYDROXY-3-METHYLGLUTARYL CoA(HMG-CoA) REDUCTASE INHIBITOR
11/24/1999	CN1236357A Aminomethylene derivatives and ultraviolet absorber comprising the same
11/23/1999	US5990322 Reacting cyclopropane carboxylic acid halide with an alpha-tocopherol in a solvent and in the presence of a base
11/23/1999	US5990305 Having at the 8-position an n-atom linked cyclic nitrogen base derived from a hindered amine light stabilizer; highdarkening and lightning velocity; intensity; longwve absorption in the active state; durability; lens; optics
11/23/1999	US5990291 Mixture of at least two isoflavones which are water insoluble at temperature from 0 to 35 degrees celsius; anticarcinogenic agents; treatment of menopause, premenstrual tension, and cardiovascular disorders
11/23/1999	US5990166 Compounds and compositions for delivering active agents
11/23/1999	US5990142 Antiinflammatory agents and antiallergens having good oral adsorption and bioavailability; cardiotonic and antiischemic agents
11/23/1999	US5990083 Composition for reducing cu/zn superoxide dismutase-1 enzyme degradation by inhibiting multicatalytic protease; treating muscle wasting diseases associated with low superoxide dismutase-1 enzyme activity
11/23/1999	US5989557 Process for extracting polyphenol fractions of tea and compositions produced therewith
11/23/1999	CA2091729C Preparation of vitamin e
11/18/1999	WO1999058710A1 7-alkoxycoumarins as cytochrome p450 substrates
11/18/1999	WO1999058496A1 Novel substituted cyclic compounds, preparation method and pharmaceutical compositions containing them
11/18/1999	WO1999058495A1 Novel substituted cyclic compounds, preparation method and pharmaceutical compositions containing them
11/18/1999	WO1999058487A1 New compounds, their preparation and use
11/18/1999	WO1999058486A1 New compounds, their preparation and use
11/18/1999	WO1999046402A3 Water-soluble coumarin fluorescent enzyme substrates
11/17/1999	EP0956285A1 Novel genipin derivative having anti hepatitis b virus activity
11/17/1999	EP0844995B1 Preparation of alpha-tocopherol
11/17/1999	EP0819135B1 Sugar-modified cytostatics
11/17/1999	CN1046507C Heterocyclic compounds for treatment of CNS and cardiovasular disorders
11/16/1999	US5986076 A conjugate is formed by bonding a bioreactive agent to the therapeutic agent with a bond that is selectively cleavable with electromagnetic radiation; useful for controlled release of drugs to treat the disorder
11/16/1999	US5986030 Cationic polymers from acrylic derivative monomers and copolymers
11/16/1999	US5985935 Treatment and prophylaxis of diseases caused by parasites, or bacteria
11/16/1999	US5985913 Tetracyclic compounds for enhancing biosynthesis of erythropoietin, compositions containing same, and methods of use thereof
11/16/1999	US5985912 4-hydroxy coumarin derivatives
11/16/1999	US5985334 Contacting test compound to receptor from rat brain tissue that binds 6-acetyl-4-benzamido-3-hydroxy-2,2-dimethylbenzopyran derivatives
11/16/1999	US5985306 (+)-enantiomers of cis-3,4-chroman derivatives useful in prevention or treatment of estrogen diseases or syndromes
11/11/1999	WO1999057221A1 Compounds for organic el element and organic el element
11/11/1999	WO1999057220A1 Compounds for organic el devices and organic el devices
11/11/1999	WO1999057107A2 Cannabinoids selective for the cb2 receptor
11/11/1999	WO1999057106A1 Novel analgesic and immunomodulatory cannabinoids
11/11/1999	WO1999056765A1 SUCCINAMIDE INHIBITORS OF INTERLEUKIN-1β CONVERTING ENZYME
11/11/1999	WO1999056743A1 Oral preparations containing forskolin derivatives and process for producing medicinal preparations
11/11/1999	WO1999040083A3 Bifunctional tryptase inhibitors
11/11/1999	CA2340445A1 Novel analgesic and immunomodulatory cannabinoids
11/11/1999	CA2340444A1 Cannabinoids selective for the cb2 receptor
11/11/1999	CA2327507A1 Succinamide inhibitors of interleukin-1.beta. converting enzyme
11/10/1999	EP0955286A1 Dihydro- or tetrahydronaphthalene derivatives having (anti-)estrogen activity
11/10/1999	EP0954761A1 Photochromic substituted naphthopyran compounds
11/10/1999	EP0954522A1 Novel substituted naphthopyrans
11/10/1999	EP0954520A1 Isoflavone derivatives, processes for the preparation thereof and pharmaceutical compositions containing them
11/10/1999	EP0954519A1 Alpha-9 integrin antagonists and anti-inflammatory compositions therof
11/10/1999	EP0954307A1 Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for inhibiting one or more symptoms of premenstrual syndrome
11/10/1999	CN1234796A Noval substituted naphthopyrans
11/10/1999	CN1234402A Process for preparing d, I-alpha-tocopherol
11/10/1999	CN1234396A Process for alkylation of hindered sulfamide
11/10/1999	CN1234391A Preparation of hydroxyl-contained organics acetate, especially linalyl acetate
11/10/1999	CN1046283C Process for preparation of 9-amino camptothecin
11/09/1999	US5981779 Enzyme linked immunoassays (elisas) (with biotin containing compounds) and fluorimetric and chemiluminometric assays (with fluorescein or chemiluminiscence containing compounds)
11/09/1999	US5981775 From a 2'-hydroxydeoxybenzoin using prepared n,n'-dimethyl(chloromethylene)ammonium chloride as a reactant in borontrifluoride etherate or other lewis acid as a solvent
11/09/1999	US5981773 Reacting a corresponding perylene-3,4:9,10-tetracarboxylic dianhydride with a sterically hindered amine, as a base, at an elevated temperature
11/09/1999	US5981770 Method for the preparation of (+)-calanolide A and analogues thereof
11/09/1999	US5981572 Treatment of disorders which arise from a disturbed functioning of systems which are regulated by melatonin; in particular in the treatment of chronobiological disorders, especially in the elderly
11/09/1999	US5981571 Benzodioxa alkylene ethers as melatonergic agents
11/09/1999	US5981495 Benzopyran derivative and method for treating heart disease using this derivative
11/09/1999	CA2177780C New arylalkyl(thio)carboxamide compounds, their preparation processes and the pharmaceutical compositions that contain them
11/04/1999	WO1999055898A1 Enzymatic resolvation for obtaining a (-)-3,4-trans-diarylchroman
11/04/1999	WO1999055308A1 Aqueous composition comprising active ingredients for the de-pigmentation of the skin
11/04/1999	WO1999055298A1 Food compositions, compositions for oral cavity and medicinal compositions for preventing or treating periodontosis and method for preventing or treating periodontosis
11/04/1999	WO1999038858A8 Benzo[b]pyran derivatives useful as external agents for the skin
11/03/1999	EP0953567A2 Bicyclic substituted piperazine-, piperidine- and tetrahydropyridine derivatives, their preparation and their use as agents with central dopaminergic (dopamine D4 receptor) activity
11/03/1999	EP0834074B1 Detection of transmembrane potentials by optical methods
11/03/1999	CN1234029A Chromene-3-carboxylate derivative
11/03/1999	CN1234020A Amide derivatives and their use as pesticides
11/02/1999	US5977385 Method for the preparation of (+)-calanolide A and analogues thereof
11/02/1999	US5977187 4-substituted-1,2-naphthoquinones and their use in the inhibition of neoplastic cell growth
11/02/1999	US5977167 Benzopyran and benzoxazine derivatives
11/02/1999	US5977157 Methods for inhibiting endometriosis
11/02/1999	US5977077 Xanthone analogs for the treatment of infectious diseases
11/02/1999	US5976397 Photofading inhibitor derivatives and their use in fabric treatment compositions
11/02/1999	CA1340806C Method, system and reagents for dna sequencing
10/1999
10/28/1999	WO1999054394A1 Stabilizer for organic polymeric material and organic polymeric material composition
10/28/1999	WO1999054286A2 Btk inhibitors and methods for their identification and use
10/28/1999	WO1999053917A1 Cannabinoids as antioxidants and neuroprotectants
10/28/1999	WO1998003497A9 Covalently immobilised fluoroionophores for optical ion sensors
10/28/1999	DE19808261A1 Arylphenylsubstituierte cyclische Ketoenole Arylphenylsubstituierte cyclic ketoenols
10/28/1999	CA2329626A1 Cannabinoids as antioxidants and neuroprotectants
10/28/1999	CA2328962A1 Btk inhibitors and methods for their identification and use
10/27/1999	CN1233182A Citrus peel extract as 3-hydroxy-3-methyl glutaryl-CoA (HMG-CoA) reductase inhibitor
10/27/1999	CN1233175A Hesperidin and hesperetin as 3-hydroxy-3-methylglutaryl CoA (HMG-CoA) reductase inhibitor
10/27/1999	CN1233174A Naringin and naringenin as 3-hydroxy-3-methylglutaryl CoA (HMG-CoA) reductase inhibitor
10/26/1999	US5973169 Ipriflavone preparation process
10/26/1999	US5972881 Treating NIDDM with RXR agonists
10/21/1999	WO1999052910A1 Bicyclic hydroxamic acid derivatives
10/21/1999	WO1999052890A1 Chromanone and thiochromanone derivatives
10/21/1999	WO1999052862A1 Process for alkylating hindered sulfonamides useful in the production of matrix metalloproteinase inhibitors

1 ... 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 174 175 176 177 178 179 ... 242